4
Changes in Ownership
BICYCLE THERAPEUTICS PLC Filed Acc 0001209191-21-046698
Chief Executive Officer sold 55,362 shares at an average $33.30 ($1,843,436)
- Chief Executive Officer acquired 45,713 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lee Kevin · Chief Executive Officer
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-12 | Exercise or conversion : show line 1 in the form | +1,936 | $14.00 | $27,104 | 256,670 | D |
| 2021-07-12 | Sale : show line 2 in the form | −1,936 | $32.04 | $62,029 | 254,734 | D |
| 2021-07-13 | Exercise or conversion : show line 3 in the form | +35,446 | $14.00 | $496,244 | 290,180 | D |
| 2021-07-13 | Sale : show line 4 in the form | −21,979 | $32.42 | $712,559 | 268,201 | D |
| 2021-07-13 | Sale : show line 5 in the form | −5,788 | $33.09 | $191,525 | 262,413 | D |
| 2021-07-13 | Sale : show line 6 in the form | −11,194 | $34.00 | $380,596 | 251,219 | D |
| 2021-07-14 | Exercise or conversion : show line 7 in the form | +8,331 | $14.00 | $116,634 | 259,550 | D |
| 2021-07-14 | Sale : show line 8 in the form | −2,642 | $32.93 | $87,001 | 256,908 | D |
| Open-market sales · 55,362 sh · avg $33.30 · $1,843,436 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-12 | Exercise or conversion : show line 12 in the form Stock Option (right to buy) | −1,936 | 412,608 | D |
| 2021-07-13 | Exercise or conversion : show line 13 in the form Stock Option (right to buy) | −35,446 | 377,162 | D |
| 2021-07-14 | Exercise or conversion : show line 14 in the form Stock Option (right to buy) | −8,331 | 368,831 | D |
Loading xslF345X03/doc4.xml…